F. Hoffmann-La Roche Ltd (secondary packaging, quality control testing, batch release; solvent (production of unpackaged product, primary packaging, secondary packaging, quality control testing, batch release))

The drug is used to treat breast cancer (metastatic or early stage) and metastatic gastric cancer or gastroesophageal junction cancer, provided there is HER2 protein overexpression in the tumor.

Dosage form: lyophilisate for concentrate for infusion solution

ATC: L01FD01